{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:47:47Z","timestamp":1793652467449,"version":"4.5.1"},"reference-count":141,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:p>Recurrent pregnancy loss (RPL) affects approximately 5% of couples. Although RPL definitions vary across professional societies, an evaluation after a second clinically recognized first-trimester pregnancy loss is recommended. Good quality evidence links parental chromosomal rearrangements, uterine anomalies, and antiphospholipid syndrome (APS) to RPL. In contrast, the relationship between RPL and other endocrine, hematologic, and immunologic disorders or environmental exposures is less clear. Anticoagulant therapy and low-dose aspirin are recommended for patients with RPL who have also been diagnosed with APS. Vaginal progesterone supplementation may be considered in patients experiencing vaginal bleeding during the first trimester. Surgical correction may be considered for patients with RPL in whom a uterine anomaly is identified. Evaluation and management of additional comorbidities should be guided by the patient's history rather than solely based on the diagnosis of RPL, with the goal of improving overall health to reduce complications in the event of pregnancy. Most people with RPL, including those without identifiable risk factors, are expected to achieve a live birth within 5 years from the initial evaluation. Nevertheless, clinicians should be sensitive to the psychological needs of individuals with this condition and provide compassionate and supportive care across all stages.<\/jats:p>","DOI":"10.1097\/aog.0000000000005498","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T17:00:26Z","timestamp":1704387626000},"page":"645-659","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":42,"title":["Evaluation of Recurrent Pregnancy Loss"],"prefix":"10.1097","volume":"143","author":[{"given":"Viviana","family":"de Assis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio Schenone","family":"Giugni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie T.","family":"Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1,4]]},"reference":[{"key":"R1-20250423","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.fertnstert.2019.11.025","article-title":"Definitions of infertility and recurrent pregnancy loss: a committee opinion","volume":"113","year":"2020","journal-title":"Fertil Steril"},{"key":"R2-20250423","doi-asserted-by":"crossref","first-page":"hoy004","DOI":"10.1093\/hropen\/hoy004","article-title":"ESHRE guideline: recurrent pregnancy loss","volume":"2018","author":"Bender Atik","year":"2018","journal-title":"Hum Reprod Open"},{"key":"R3-20250423","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198807283190401","article-title":"Incidence of early loss of pregnancy","volume":"319","author":"Wilcox","year":"1988","journal-title":"N Engl J Med"},{"key":"R4-20250423","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/ppe.12417","article-title":"Trends in risk of pregnancy loss among US women, 1990-2011","volume":"32","author":"Rossen","year":"2018","journal-title":"Paediatr Perinat Epidemiol"},{"key":"R5-20250423","first-page":"447","article-title":"Recurrent pregnancy loss: clinical evidence for suboptimal implantation","volume":"12","author":"Stephenson","year":"2001","journal-title":"Infertil Reprod Med Clin North Am"},{"key":"R6-20250423","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.semperi.2018.12.003","article-title":"Uterine factor in recurrent pregnancy loss","volume":"43","author":"Turocy","year":"2019","journal-title":"Semin Perinatol"},{"key":"R7-20250423","first-page":"163","article-title":"Prevalence of uterine anatomical anomalies in Mexican women with recurrent pregnancy loss (RPL) [in Spanish]","volume":"152","author":"Medrano-Uribe","year":"2016","journal-title":"Gac Med Mex"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00404-006-0202-7","article-title":"Prevalence of uterine defects in habitual abortion patients attended on at a university health service in Brazil","volume":"274","author":"Guimar\u00e3es Filho","year":"2006","journal-title":"Arch Gynecol Obstet"},{"key":"R9-20250423","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.fertnstert.2020.12.003","article-title":"Uterine factors in recurrent pregnancy losses","volume":"115","author":"Carbonnel","year":"2021","journal-title":"Fertil Steril"},{"key":"R10-20250423","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0140-6736(90)92159-F","article-title":"Recurrent miscarriage","volume":"336","author":"Stirrat","year":"1990","journal-title":"Lancet"},{"key":"R11-20250423","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/molehr\/gar003","article-title":"A genome-wide scan in affected sibling pairs with idiopathic recurrent miscarriage suggests genetic linkage","volume":"17","author":"Kolte","year":"2011","journal-title":"Mol Hum Reprod"},{"key":"R12-20250423","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00404-017-4532-4","article-title":"Fertility after recurrent miscarriages: results of an observational cohort study","volume":"297","author":"Kling","year":"2018","journal-title":"Arch Gynecol Obstet"},{"key":"R13-20250423","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/humrep\/deq089","article-title":"Consecutive or non-consecutive recurrent miscarriage: is there any difference in carrier status?","volume":"25","author":"van den Boogaard","year":"2010","journal-title":"Hum Reprod"},{"key":"R14-20250423","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.fertnstert.2012.09.002","article-title":"Number and sequence of preceding miscarriages and maternal age for the prediction of antiphospholipid syndrome in women with recurrent miscarriage","volume":"99","author":"van den Boogaard","year":"2013","journal-title":"Fertil Steril"},{"key":"R15-20250423","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.rbmo.2020.05.016","article-title":"Defining recurrent pregnancy loss: associated factors and prognosis in couples with two versus three or more pregnancy losses","volume":"41","author":"Youssef","year":"2020","journal-title":"Reprod Biomed Online"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/humrep\/dew169","article-title":"Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses?","volume":"31","author":"Egerup","year":"2016","journal-title":"Hum Reprod"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1111\/1471-0528.17515","article-title":"Recurrent miscarriage: Green-top Guideline No. 17","volume":"130","author":"Regan","year":"2023","journal-title":"BJOG"},{"key":"R18-20250423","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000325165","article-title":"Relationship between recurrent miscarriage and insulin resistance","volume":"72","author":"Wang","year":"2011","journal-title":"Gynecol Obstet Invest"},{"key":"R20-20250423","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/uog.204","article-title":"Fetal loss following ultrasound diagnosis of a live fetus at 6-10 weeks of gestation","volume":"22","author":"Makrydimas","year":"2003","journal-title":"Ultrasound Obstet Gynecol"},{"key":"R21-20250423","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1136\/bmj.320.7251.1708","article-title":"Maternal age and fetal loss: population based register linkage study","volume":"320","author":"Nybo Andersen","year":"2000","journal-title":"BMJ"},{"key":"R22-20250423","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1126\/science.aav7321","article-title":"Chromosome errors in human eggs shape natural fertility over reproductive life span","volume":"365","author":"Gruhn","year":"2019","journal-title":"Science"},{"key":"R23-20250423","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41572-020-00228-z","article-title":"Recurrent pregnancy loss","volume":"6","author":"Dimitriadis","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"R24-20250423","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10815-017-1108-y","article-title":"Genetic and epigenetic variations associated with idiopathic recurrent pregnancy loss","volume":"35","author":"Arias-Sosa","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"R25-20250423","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0015-0282(16)58565-3","article-title":"Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies","volume":"66","author":"Yetman","year":"1996","journal-title":"Fertil Steril"},{"key":"R26-20250423","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1097\/01.AOG.0000423816.39542.0f","article-title":"Antiphospholipid syndrome. Practice Bulletin No.132. American College of Obstetricians and Gynecologists","volume":"120","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R27-20250423","doi-asserted-by":"crossref","first-page":"e059519","DOI":"10.1136\/bmjopen-2021-059519","article-title":"Thrombophilia screening in women with recurrent first trimester miscarriage: is it time to stop testing?\u2014a cohort study and systematic review of the literature","volume":"12","author":"Shehata","year":"2022","journal-title":"BMJ Open"},{"key":"R28-20250423","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ogc.2013.10.004","article-title":"Antiphospholipid antibody syndrome","volume":"41","author":"Kutteh","year":"2014","journal-title":"Obstet Gynecol Clin North America"},{"key":"R29-20250423","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/acr.22066","article-title":"Estimated frequency of antiphospholipid antibodies in patients with pregnancy morbidity, stroke, myocardial infarction, and deep vein thrombosis: a critical review of the literature","volume":"65","author":"Andreoli","year":"2013","journal-title":"Arthritis Care Res"},{"key":"R30-20250423","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1093\/humrep\/des179","article-title":"Abnormal embryonic karyotype is the most frequent cause of recurrent miscarriage","volume":"27","author":"Sugiura-Ogasawara","year":"2012","journal-title":"Hum Reprod"},{"key":"R31-20250423","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.fertnstert.2012.04.007","article-title":"Cost-effectiveness of cytogenetic evaluation of products of conception in the patient with a second pregnancy loss","volume":"98","author":"Foyouzi","year":"2012","journal-title":"Fertil Steril"},{"key":"R32-20250423","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/TACG.S320778","article-title":"Genetic testing for aneuploidy in patients who have had multiple miscarriages: a review of current literature","volume":"14","author":"Papas","year":"2021","journal-title":"Appl Clin Genet"},{"key":"R33-20250423","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","article-title":"Evaluation and treatment of recurrent pregnancy loss: a committee opinion","volume":"98","year":"2012","journal-title":"Fertil Steril"},{"key":"R34-20250423","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/humrep\/dei417","article-title":"Reproductive outcomes in recurrent pregnancy loss associated with a parental carrier of a structural chromosome rearrangement","volume":"21","author":"Stephenson","year":"2006","journal-title":"Hum Reprod"},{"key":"R35-20250423","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1093\/humrep\/deg309","article-title":"Embryoscopic and cytogenetic analysis of 233 missed abortions: factors involved in the pathogenesis of developmental defects of early failed pregnancies","volume":"18","author":"Philipp","year":"2003","journal-title":"Hum Reprod"},{"key":"R36-20250423","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/j.semperi.2018.12.002","article-title":"Genetic abnormalities and pregnancy loss","volume":"43","author":"Blue","year":"2019","journal-title":"Semin Perinatol"},{"key":"R37-20250423","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0020-7292(02)00197-2","article-title":"ACOG Practice Bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin number 212, September 1995). American College of Obstetricians and Gynecologists","volume":"78","year":"2002","journal-title":"Int J Gynaecol Obstet"},{"key":"R38-20250423","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"},{"key":"R39-20250423","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/humupd\/dmr024","article-title":"Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review","volume":"17","author":"Van den Boogaard","year":"2011","journal-title":"Hum Reprod Update"},{"key":"R40-20250423","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/0019-5359.43122","article-title":"Prevalence of hypothyroidism in recurrent pregnancy loss in first trimester","volume":"62","author":"Sadhnani","year":"2008","journal-title":"Indian J Med Sci"},{"key":"R41-20250423","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.beem.2004.03.012","article-title":"Maternal thyroid hormones early in pregnancy and fetal brain development","volume":"18","author":"de Escobar","year":"2004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R42-20250423","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.1097\/AOG.0000000000003893","article-title":"Thyroid disease in pregnancy. ACOG Practice Bulletin No. 223. American College of Obstetricians and Gynecologists","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R43-20250423","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/humupd\/dmv004","article-title":"Pathophysiological aspects of thyroid hormone disorders\/thyroid peroxidase autoantibodies and reproduction","volume":"21","author":"Vissenberg","year":"2015","journal-title":"Hum Reprod Update"},{"key":"R44-20250423","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0394632015615130","article-title":"Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure","volume":"29","author":"Triggianese","year":"2016","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R45-20250423","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.fertnstert.2013.07.1975","article-title":"Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss","volume":"100","author":"Bernardi","year":"2013","journal-title":"Fertil Steril"},{"key":"R46-20250423","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1812537","article-title":"Levothyroxine in women with thyroid peroxidase antibodies before conception","volume":"380","author":"Dhillon-Smith","year":"2019","journal-title":"New Engl J Med"},{"key":"R47-20250423","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S2213-8587(22)00045-6","article-title":"Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"10","author":"van Dijk","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R48-20250423","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bpobgyn.2004.11.005","article-title":"Evidence-based care of recurrent miscarriage","volume":"19","author":"Porter","year":"2005","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R49-20250423","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2006-931799","article-title":"Endocrinology of recurrent pregnancy loss","volume":"24","author":"Arredondo","year":"2006","journal-title":"Semin Reprod Med"},{"key":"R50-20250423","article-title":"Progestogens for preventing miscarriage: a network meta-analysis","author":"Devall","year":"2021","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R51-20250423","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humrep\/dead029","article-title":"Progesterone for women with threatened miscarriage (STOP trial): a placebo-controlled randomized clinical trial","volume":"38","author":"McLindon","year":"2023","journal-title":"Hum Reprod"},{"key":"R52-20250423","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bpobgyn.2020.09.002","article-title":"Sporadic pregnancy loss and recurrent miscarriage","volume":"69","author":"Devall","year":"2020","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R53-20250423","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003511.pub5","article-title":"Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology","author":"Haas","year":"2019","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R54-20250423","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1056\/NEJMoa1504927","article-title":"A randomized trial of progesterone in women with recurrent miscarriages","volume":"373","author":"Coomarasamy","year":"2015","journal-title":"N Engl J Med"},{"key":"R55-20250423","first-page":"2172","article-title":"Differential roles for signal transducers and activators of transcription 5a and 5b in PRL stimulation of ERalpha and ERbeta transcription","volume":"15","author":"Frasor","year":"2001","journal-title":"Mol Endocrinol"},{"key":"R56-20250423","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM198812223192501","article-title":"Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception","volume":"319","author":"Mills","year":"1988","journal-title":"N Engl J Med"},{"key":"R57-20250423","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/qjmed\/94.8.435","article-title":"Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis","volume":"94","author":"Ray","year":"2001","journal-title":"QJM"},{"key":"R58-20250423","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s005920050077","article-title":"Glycosylated hemoglobin as predictor of adverse fetal outcome in type 1 diabetic pregnancies","volume":"34","author":"Nielsen","year":"1997","journal-title":"Acta Diabetol"},{"key":"R59-20250423","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/tera.1420390303","article-title":"First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy","volume":"39","author":"Greene","year":"1989","journal-title":"Teratology"},{"issue":"suppl 1","key":"R60-20250423","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.2337\/dc23-S015","article-title":"15. Management of diabetes in pregnancy: Standards of care in diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"R61-20250423","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1016\/j.fertnstert.2010.07.754","article-title":"Insulin resistance, homocysteine & pregnancy loss in polycystic ovarian syndrome (PCOS): are they related? [abstract]","volume":"94","author":"Rajani","year":"2010","journal-title":"Fertil Steril"},{"key":"R62-20250423","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.3390\/jcm9092700","article-title":"The prevalence and impact of polycystic ovary syndrome in recurrent miscarriage: a retrospective cohort study and meta-analysis","volume":"9","author":"Mayrhofer","year":"2020","journal-title":"J Clin Med"},{"key":"R63-20250423","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1472-6483(10)60304-5","article-title":"A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage","volume":"17","author":"Cocksedge","year":"2008","journal-title":"Reprod Biomed Online"},{"key":"R64-20250423","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0015-0282(02)03247-8","article-title":"Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss","volume":"78","author":"Craig","year":"2002","journal-title":"Fertil Steril"},{"key":"R65-20250423","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.tjog.2013.06.020","article-title":"Effect of metformin on early pregnancy loss in women with polycystic ovary syndrome","volume":"54","author":"Al-Biate","year":"2015","journal-title":"Taiwan J Obstet Gynecol"},{"key":"R66-20250423","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jcem.87.2.8207","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome","volume":"87","author":"Jakubowicz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R67-20250423","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/humupd\/dmr028","article-title":"The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review","volume":"17","author":"Chan","year":"2011","journal-title":"Hum Reprod Update"},{"key":"R68-20250423","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.rbmo.2009.11.021","article-title":"The pattern of pregnancy loss in women with congenital uterine anomalies and recurrent miscarriage","volume":"20","author":"Saravelos","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"R69-20250423","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/1471-0528.15968","article-title":"Reproductive implications and management of congenital uterine anomalies: Scientific impact paper No. 62 November 2019","volume":"127","author":"Akhtar","year":"2020","journal-title":"BJOG"},{"key":"R70-20250423","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijgo.2008.11.017","article-title":"Technique and diagnostic utility of saline infusion sonohysterography","volume":"105","author":"Elsayes","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"R71-20250423","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1016\/j.fertnstert.2010.03.047","article-title":"A prospective comparison of transvaginal ultrasound, saline infusion sonohysterography, and diagnostic hysteroscopy in the evaluation of endometrial pathology","volume":"94","author":"Grimbizis","year":"2010","journal-title":"Fertil Steril"},{"key":"R72-20250423","first-page":"168","article-title":"Pregnancy rates after hysteroscopic polypectomy and myomectomy in infertile women","volume":"94","author":"Varasteh","year":"1999","journal-title":"Obstet Gynecol"},{"key":"R73-20250423","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jmig.2023.07.012","article-title":"Uterine septum and other mullerian anomalies in a recurrent pregnancy loss population: impact on reproductive outcomes","volume":"30","author":"Fayek","year":"2023","journal-title":"J Minim Invasive Gynecol"},{"key":"R74-20250423","doi-asserted-by":"crossref","first-page":"17103","DOI":"10.1038\/nrdp.2017.103","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"R75-20250423","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/art.40901","article-title":"The epidemiology of antiphospholipid syndrome: a population-based study","volume":"71","author":"Duarte-Garc\u00eda","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"R76-20250423","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/sj.thj.6200206","article-title":"Antiphospholipid antibodies and thrombosis: strength of association","volume":"4","author":"Galli","year":"2003","journal-title":"Hematol J"},{"key":"R77-20250423","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/jaut.2000.0409","article-title":"Epidemiology of the antiphospholipid antibody syndrome","volume":"15","author":"Petri","year":"2000","journal-title":"J Autoimmun"},{"key":"R78-20250423","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jri.2017.09.007","article-title":"Antiphospholipid syndrome and recurrent miscarriage: a systematic review and meta-analysis","volume":"123","author":"Santos","year":"2017","journal-title":"J Reprod Immunol"},{"key":"R79-20250423","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/0961203320954520","article-title":"16th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome","volume":"29","author":"de Jes\u00fas","year":"2020","journal-title":"Lupus"},{"key":"R80-20250423","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M14-2235","article-title":"Predictors of pregnancy outcomes in patients with lupus: a cohort study","volume":"163","author":"Buyon","year":"2015","journal-title":"Ann Intern Med"},{"key":"R81-20250423","doi-asserted-by":"crossref","first-page":"525.e1","DOI":"10.1016\/j.ajog.2017.01.026","article-title":"Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study","volume":"216","author":"Saccone","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"R82-20250423","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1055\/s-0037-1603936","article-title":"Prevalence and thrombotic risk assessment of anti-\u03b22 glycoprotein I domain I antibodies: a systematic review","volume":"44","author":"Radin","year":"2018","journal-title":"Semin Thromb Hemost"},{"key":"R83-20250423","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1182\/bloodadvances.2021005205","article-title":"A systematic review of the association between anti-beta-2 glycoprotein I antibodies and APS manifestations","volume":"5","author":"Jiang","year":"2021","journal-title":"Blood Adv"},{"key":"R84-20250423","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"R85-20250423","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/0961203320967097","article-title":"Prevention of recurrent miscarriage in women with antiphospholipid syndrome: a systematic review and network meta-analysis","volume":"30","author":"Yang","year":"2021","journal-title":"Lupus"},{"key":"R86-20250423","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00006250-200212000-00032","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R87-20250423","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s00404-011-2055-y","article-title":"Bemiparin versus low dose aspirin for management of recurrent early pregnancy losses due to antiphospholipd antibody syndrome","volume":"285","author":"Alalaf","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"R88-20250423","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3109\/01443615.2010.518651","article-title":"Efficacy and safety of two doses of low molecular weight heparin (enoxaparin) in pregnant women with a history of recurrent abortion secondary to antiphospholipid syndrome","volume":"30","author":"Fouda","year":"2010","journal-title":"J Obstet Gynaecol"},{"key":"R89-20250423","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial","volume":"36","author":"Laskin","year":"2009","journal-title":"J Rheumatol"},{"key":"R90-20250423","doi-asserted-by":"crossref","DOI":"10.1111\/aji.12770","article-title":"Use of D-dimer measurement to guide anticoagulant treatment in recurrent pregnancy loss associated with antiphospholipid syndrome","volume":"78","author":"Bao","year":"2017","journal-title":"Am J Reprod Immunol"},{"key":"R91-20250423","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S1701-2163(16)30644-2","article-title":"Treatment of antiphospholipid antibody syndrome (APS) in pregnancy: a randomized pilot trial comparing low molecular weight heparin to unfractionated heparin","volume":"26","author":"Stephenson","year":"2004","journal-title":"J Obstet Gynaecol Can"},{"key":"R92-20250423","doi-asserted-by":"crossref","first-page":"273.e1","DOI":"10.1016\/j.ajog.2015.09.078","article-title":"The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies","volume":"214","author":"Sciascia","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R93-20250423","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/s-0037-1603359","article-title":"HYdroxychloroquine to improve pregnancy outcome in women with AnTIphospholipid antibodies (HYPATIA) protocol: a multinational randomized controlled trial of hydroxychloroquine versus placebo in addition to standard treatment in pregnant women with antiphospholipid syndrome or antibodies","volume":"43","author":"Schreiber","year":"2017","journal-title":"Semin Thromb Hemost"},{"key":"R94-20250423","first-page":"598","article-title":"Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL","volume":"46","author":"Mekinian","year":"2018","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"R95-20250423","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.autrev.2018.05.012","article-title":"HIBISCUS: hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome","volume":"17","author":"Belizna","year":"2018","journal-title":"Autoimmun Rev"},{"key":"R96-20250423","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1160\/th15-06-0491","article-title":"The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment","volume":"115","author":"Sciascia","year":"2016","journal-title":"Thromb Haemost"},{"key":"R97-20250423","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1387\/ijdb.082763jb","article-title":"Immune cells in the placental bed","volume":"54","author":"Bulmer","year":"2010","journal-title":"Int J Dev Biol"},{"key":"R98-20250423","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.3390\/ijms20215332","article-title":"Endometrial immune dysfunction in recurrent pregnancy loss","volume":"20","author":"Ticconi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R99-20250423","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1096\/fasebj.6.6.1544544","article-title":"HLA and maternal-fetal recognition","volume":"6","author":"Hunt","year":"1992","journal-title":"FASEB J"},{"key":"R100-20250423","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1600-0897.2010.00821.x","article-title":"Regulatory T cells and their role in pregnancy","volume":"63","author":"Leber","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"R101-20250423","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.aaw1300","article-title":"The immunological code of pregnancy","volume":"365","author":"Colucci","year":"2019","journal-title":"Science"},{"key":"R102-20250423","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1002\/iid3.474","article-title":"Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion","volume":"9","author":"Liu","year":"2021","journal-title":"Immun Inflamm Dis"},{"key":"R103-20250423","doi-asserted-by":"crossref","first-page":"e13605","DOI":"10.1111\/aji.13605","article-title":"Efficacy of lymphocyte immunotherapy in the treatment of recurrent pregnancy loss from alloimmunity: a systematic review and meta-analysis","volume":"88","author":"Francisco","year":"2022","journal-title":"Am J Reprod Immunol"},{"key":"R104-20250423","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/jcpt.13629","article-title":"Oral immunosuppressants improve pregnancy outcomes in women with idiopathic recurrent miscarriage: a meta-analysis","volume":"47","author":"Ma","year":"2022","journal-title":"J Clin Pharm Ther"},{"key":"R105-20250423","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/aji.12373","article-title":"Effect of prednisolone administration on patients with unexplained recurrent miscarriage and in routine intracytoplasmic sperm injection: a meta-analysis","volume":"74","author":"Dan","year":"2015","journal-title":"Am J Reprod Immunol"},{"key":"R106-20250423","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJM199707173370302","article-title":"Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss","volume":"337","author":"Laskin","year":"1997","journal-title":"N Engl J Med"},{"key":"R107-20250423","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.bpobgyn.2019.07.005","article-title":"Immunotherapy for recurrent pregnancy loss","volume":"60","author":"Carp","year":"2019","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"R108-20250423","doi-asserted-by":"crossref","first-page":"e13200","DOI":"10.1111\/aji.13200","article-title":"The pathogenic role of autoantibodies in recurrent pregnancy loss","volume":"83","author":"D'Ippolito","year":"2020","journal-title":"Am J Reprod Immunol"},{"key":"R109-20250423","doi-asserted-by":"crossref","first-page":"103794","DOI":"10.1016\/j.jri.2022.103794","article-title":"Antinuclear antibodies positivity in women in reproductive age: from infertility to adverse obstetrical outcomes - a meta-analysis","volume":"155","author":"Ticconi","year":"2023","journal-title":"J Reprod Immunol"},{"key":"R110-20250423","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ijgo.13556","article-title":"Association of prednisone and antinuclear antibodies with pregnancy outcomes in women with unexplained recurrent pregnancy loss","volume":"154","author":"Sun","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"R111-20250423","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.fertnstert.2005.12.035","article-title":"A combination treatment of prednisone, aspirin, folate, and progesterone in women with idiopathic recurrent miscarriage: a matched-pair study","volume":"86","author":"Tempfer","year":"2006","journal-title":"Fertil Steril"},{"key":"R112-20250423","doi-asserted-by":"crossref","first-page":"819406","DOI":"10.3389\/fmed.2022.819406","article-title":"Glucocorticoids improve the pregnancy rate and outcome in women with unexplained positive autoantibodies: a systematic review and meta-analysis","volume":"9","author":"Li","year":"2022","journal-title":"Front Med"},{"key":"R113-20250423","doi-asserted-by":"crossref","DOI":"10.1186\/2054-7099-1-5","article-title":"Time to next pregnancy in spontaneous pregnancies versus treatment cycles in fertile patients with recurrent pregnancy loss","author":"Perfetto","year":"2015","journal-title":"Fertil Res Pract"},{"key":"R114-20250423","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/humrep\/dew135","article-title":"Intent to treat analysis of in vitro fertilization and preimplantation genetic screening versus expectant management in patients with recurrent pregnancy loss","volume":"31","author":"Murugappan","year":"2016","journal-title":"Hum Reprod"},{"key":"R115-20250423","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1055\/s-0031-1293204","article-title":"Does obesity increase the risk of miscarriage in spontaneous conception: a systematic review","volume":"29","author":"Boots","year":"2011","journal-title":"Semin Reprod Med"},{"key":"R116-20250423","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/2229-516X.179024","article-title":"Endocrine dysfunction and recurrent spontaneous abortion: an overview","volume":"6","author":"Kaur","year":"2016","journal-title":"Int J Appl Basic Med Res"},{"key":"R117-20250423","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.1038\/s41598-021-86445-2","article-title":"Systematic review and meta-analysis of female lifestyle factors and risk of recurrent pregnancy loss","volume":"11","author":"Ng","year":"2021","journal-title":"Sci Rep"},{"key":"R118-20250423","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1111\/acer.14124","article-title":"Alcohol use in pregnancy and miscarriage: a systematic review and meta-analysis","volume":"43","author":"Sundermann","year":"2019","journal-title":"Alcohol Clin Exp Res"},{"key":"R119-20250423","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10654-010-9443-7","article-title":"Caffeine intake during pregnancy, late miscarriage and stillbirth","volume":"25","author":"Greenwood","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R120-20250423","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/01.ede.0000229984.53726.33","article-title":"Environmental tobacco smoke and risk of spontaneous abortion","volume":"17","author":"George","year":"2006","journal-title":"Epidemiology"},{"key":"R121-20250423","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/EDE.0b013e3181e57008","article-title":"Smoking and miscarriage risk [letter]","volume":"21","author":"Farioli","year":"2010","journal-title":"Epidemiology"},{"key":"R122-20250423","doi-asserted-by":"crossref","first-page":"886224","DOI":"10.3389\/fnut.2022.886224","article-title":"Relationship between maternal caffeine and coffee intake and pregnancy loss: a grading of recommendations assessment, development, and evaluation-assessed, dose-response meta-analysis of observational studies","volume":"9","author":"Jafari","year":"2022","journal-title":"Front Nutr"},{"key":"R123-20250423","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejogrb.2011.04.024","article-title":"Maternal caffeine consumption and sine causa recurrent miscarriage","volume":"158","author":"Stefanidou","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R124-20250423","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/humrep\/det424","article-title":"Vitamin D deficiency may be a risk factor for recurrent pregnancy losses by increasing cellular immunity and autoimmunity","volume":"29","author":"Ota","year":"2014","journal-title":"Hum Reprod"},{"key":"R125-20250423","doi-asserted-by":"crossref","first-page":"e12991","DOI":"10.1111\/aji.12991","article-title":"Vitamin D, autoimmunity and recurrent pregnancy loss: more than an association","volume":"80","author":"Sharif","year":"2018","journal-title":"Am J Reprod Immunol"},{"key":"R126-20250423","doi-asserted-by":"crossref","first-page":"382","DOI":"10.3892\/mmr.2021.12021","article-title":"A novel update on vitamin D in recurrent pregnancy loss (Review)","volume":"23","author":"Zhao","year":"2021","journal-title":"Mol Med Rep"},{"key":"R127-20250423","doi-asserted-by":"crossref","first-page":"e13022","DOI":"10.1111\/aji.13022","article-title":"Recurrent pregnancy loss and vitamin D: a review of the literature","volume":"80","author":"Gon\u00e7alves","year":"2018","journal-title":"Am J Reprod Immunol"},{"key":"R128-20250423","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.fertnstert.2022.04.017","article-title":"Vitamin D and miscarriage: a systematic review and meta-analysis","volume":"118","author":"Tamblyn","year":"2022","journal-title":"Fertil Steril"},{"key":"R129-20250423","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/ajo.12373","article-title":"Sperm DNA fragmentation abnormalities in men from couples with a history of recurrent miscarriage","volume":"55","author":"Leach","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R130-20250423","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.fertnstert.2019.03.003","article-title":"Sperm DNA fragmentation and recurrent pregnancy loss: a systematic review and meta-analysis","volume":"112","author":"McQueen","year":"2019","journal-title":"Fertil Steril"},{"key":"R131-20250423","first-page":"48","article-title":"DNA methylation defects in spermatozoa of male partners from couples experiencing recurrent pregnancy loss","volume":"36","author":"Khambata","year":"2021","journal-title":"Hum Reprod"},{"key":"R132-20250423","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.fertnstert.2003.08.020","article-title":"Possible role of bacterial and viral infections in miscarriages","volume":"81","author":"Matovina","year":"2004","journal-title":"Fertil Steril"},{"key":"R133-20250423","first-page":"2207","article-title":"Relation between mycoplasma infection and recurrent spontaneous abortion","volume":"22","author":"Cao","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R134-20250423","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.fertnstert.2018.04.012","article-title":"Endometritis: new time, new concepts","volume":"110","author":"Kitaya","year":"2018","journal-title":"Fertil Steril"},{"key":"R135-20250423","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1600-0897.2011.01051.x","article-title":"Immunohistochemistrical and clinicopathological characterization of chronic endometritis","volume":"66","author":"Kitaya","year":"2011","journal-title":"Am J Reprod Immunol"},{"key":"R136-20250423","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.fertnstert.2018.01.022","article-title":"Comparison of the prevalence of chronic endometritis as determined by means of different diagnostic methods in women with and without reproductive failure","volume":"109","author":"Liu","year":"2018","journal-title":"Fertil Steril"},{"key":"R137-20250423","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.fertnstert.2020.12.010","article-title":"Endometrial causes of recurrent pregnancy losses: endometriosis, adenomyosis, and chronic endometritis","volume":"115","author":"Pirtea","year":"2021","journal-title":"Fertil Steril"},{"key":"R138-20250423","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/humrep\/deaa326","article-title":"Chance of live birth: a nationwide, registry-based cohort study","volume":"36","author":"Kolte","year":"2021","journal-title":"Hum Reprod"},{"key":"R139-20250423","first-page":"hoad002","article-title":"ESHRE guideline: recurrent pregnancy loss: an update in 2022","volume":"2023","author":"Bender Atik","year":"2023","journal-title":"Hum Reprod Open"},{"key":"R140-20250423","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/humrep\/dev014","article-title":"Depression and emotional stress is highly prevalent among women with recurrent pregnancy loss","volume":"30","author":"Kolte","year":"2015","journal-title":"Hum Reprod"},{"key":"R141-20250423","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jgyn.2014.09.010","article-title":"Definition of pregnancy losses: standardization of terminology from the French National College of Obstetricians and Gynecologists (CNGOF) [in French]","volume":"43","author":"Delabaere","year":"2014","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"R142-20250423","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005498","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T13:02:38Z","timestamp":1745413358000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,4]]},"references-count":141,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005498","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,4]]},"assertion":[{"value":"2023-07-31","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}